SEC Filing Document

Company: DUKE Robotics Corp.
Ticker: DUKR
CIK: 1638911
Filing Type: DRS
Document Type: DRS
Date Filed: 2025-12-22
Accession Number: 0001213900-25-124553
Exchange: OTC
SIC Code: 3721
SIC Description: Aircraft
URL: https://www.sec.gov/Archives/edgar/data/1638911/000121390025124553/filename1.htm

Chunk 26 of 51
Word Count: 1498
Character Count: 9476

Document Content:

are interested in communicating directly with members of the Board, or the Board as a group, may do so by writing directly to the individual Board member c/o Secretary, DUKE Robotics Corp., 10 HaRimon Street, Mevo Carmel Science and Industrial Park, Israel 2069203. The Company’s Secretary will forward communications directly to the appropriate Board member. If the correspondence is not addressed to the particular member, the communication will be forwarded to a Board member to bring to the attention of the Board. The Company’s Secretary will review all communications before forwarding them to the appropriate Board member. EXECUTIVE AND DIRECTOR COMPENSATION Compensation of Executive Officers The compensation of our named executive officers is determined by our Board of Directors, with the objective of attracting and retaining qualified executives, aligning executive compensation with our business objectives and stockholder interests, and rewarding performance and contribution to the Company. Cash Compensation and Bonuses

For the fiscal year ended
December 31, 2024, the primary component of our named executive officers’ compensation consisted of base salary. We did not maintain
a formal bonus or incentive cash compensation plan for our executive officers during 2024, and no discretionary or performance-based cash
bonuses were awarded to our named executive officers for that year. Accordingly, the amounts reflected in the “Bonus” column
of the Summary Compensation Table, if any, represent discretionary payments approved by the Board based on overall performance and service
to the Company rather than pursuant to any pre-established performance targets or formula.

Equity-Based Compensation

We use equity-based compensation to align the interests
of our executive officers and directors with those of our stockholders and to incentivize long-term value creation. Equity awards are
granted at the discretion of our Board of Directors pursuant to our 2021 Equity Incentive Plan (the “2021 Plan”).

As disclosed under “Summary
Information about Equity Compensation Plans,” on March 18, 2025, our Board approved grants of stock options to certain executive
officers and directors, including 1,000,000 options to purchase shares of our common stock to Mr. Yossef Balucka, our Chief Executive
Officer, and 50,000 options to purchase shares of our common stock to Mr. Shlomo Zakai, our Chief Financial Officer. These option awards
were granted in consideration of the recipients’ roles, responsibilities, experience and continued service to the Company.

All option awards granted
under the 2021 Plan are subject to vesting conditions determined by the Board at the time of grant, typically based on continued service
with the Company. The options generally have a term of six years from the date of grant, subject to earlier termination in certain circumstances,
including cessation of service.

Outstanding Equity Awards

As of December 31, 2024, there were no outstanding
vested or unvested equity awards held by our named executive officers, except as disclosed in the tables captioned “Outstanding
Equity Awards at Fiscal Year End” and “Grants of Plan-Based Awards.”

Other Compensation Arrangements

We do not maintain any pension, retirement, deferred
compensation, severance or change-in-control arrangements for our executive officers, other than benefits required to be provided under
applicable Israeli law. As of December 31, 2024, none of our named executive officers had employment agreements that provided for severance
or other post-employment payments

The following summary compensation
table sets forth all compensation awarded to, earned by, or paid to the named executive officers paid by the Company during the fiscal
year ended December 31, 2024, in all capacities for the accounts of our executive officers, including the Chief Executive Officer.

Summary Compensation Table

Name and principal position Year Salary ($) Bonus ($) Stock awards ($) Option awards ($) Non-equity incentive plan compensation ($) Change in Pension Value and Nonqualified deferred compensation earnings ($) All other compensation ($) Total ($)

Yossef -Bakula 2023 97,568 0 0 20,864 0 0 0 118,432

CEO 2024 110,549 31,830 0 3,149 0 0 0 145,528

Shlomo Zakai - 2023 35,262 0 0 2,685 0 0 0 37,947

CFO 2024 22,957 0 0 793 0 0 0 23,750

Restricted Stock Awards

There were no shares of restricted stock awarded during the Company’s fiscal year ended December 31, 2024.

OUTSTANDING EQUITY AWARDS AT DECEMBER 31, 2024

Outstanding Equity Awards at Fiscal Year
End

There are no outstanding equity
awards for the year ended December 31, 2024 except as disclosed below.

Grants of Plan-Based Awards for 2024

The following table presents
the outstanding equity awards held as of December 31, 2024 by our named executive officers and directors, all of which have been issued
pursuant to our 2021 Equity Incentive Plan, or the 2021 Plan:

Name Number
shares
that have
not vested
(#) Market
value of
shares
that have
not vested
($) Equity
incentive
plan
awards:
Number of
shares
that have
not vested
(#) Equity
incentive
plan
awards:
Market
value of
shares
that have
not vested

Yossef Bakula - - - -

Erez Nachtomy - - - -

Eran Antebi - - - -

Sagiv Aharon - - - -

Shlomo Zakai - - - -

Pension Benefits

We have no arrangements or
plans, except for those we are obligated to maintain pursuant to the Israeli law, under which we provide pension, retirement or similar
benefits for directors or executive officers. Our directors and executive officers may receive share options or restricted shares at the
discretion of our Board in the future.

Nonqualified Deferred Compensation

The Company does not have
a Deferred Compensation Plan for its executive officers.

Other Potential Post-Employment Payments

As of December 31, 2024, there
were no named executives with employment contracts that require or required severance or other post-employment payments.

Summary Information about Equity Compensation
Plans

Equity Compensation Plan Information

On May 27, 2021, our Board
of Directors approved the 2021 Plan, pursuant to which we may issue awards, from time to time, consisting of non-qualified stock options,
restricted stock grants and restricted stock units (“RSUs”). In addition, stock option awards that qualify under Section 102
of the Israeli Tax Ordinance (New Version) 1961 (the “ITO”), and/or under Section 3(i) of the ITO, may be granted. A summary
of the 2021 Plan is found below.

Under the 2021 Plan, options, restricted share and RSUs may be granted
to our officers, directors, employees and consultants or the officers, directors, employees and consultants of our subsidiary. On March
18, 2025, our Board approved an increase in the amount of shares of common stock available under the 2021 Plan from 4,800,000 to 9,000,000.
To the extent that an award lapses or is forfeited, the shares subject to such Award will again become available for grant under the terms
of the 2021 Plan.

We do not have any formal
policy that requires the Company to grant, or avoid granting, equity-based compensation at certain times. We do not grant equity awards
in anticipation of the release of material nonpublic information that is likely to result in changes to the price of our common stock,
and do not time the public release of such information based on award grant dates. The timing of any equity grants to executive officers
or directors in connection with new hires, promotions, or other non-routine grants is tied to the event giving rise to the award (such
as an executive officer’s commencement of employment or promotion effective date).

On March 18, 2025, our Board approved the following grants: (i) 1,000,000
options to purchase shares of common stock to Mr. Yossef Balucka, our CEO; (ii) 500,000 options to purchase shares of common stock to
Mr. Vadim Maor, our CTO, (iii) 120,000 options to purchase shares of common stock to Ms. Gousman, our newly appointed Director, (iv) 400,000
options to purchase shares of common stock to Mrs. Alexandra Papaconstantinou the appointed Managing Director of Duke Greece, (v) 50,000
options to purchase shares of common stock to Mr. Shlomo Zakai, our CFO.

No Loans for Option Exercises.
It is our policy to not make loans to employees or officers for the purpose of paying for the exercise of stock options.

Director Compensation

We reimburse directors for
out-of-pocket expenses they incur when attending meetings of the board of directors. On April 12, 2020, effective as of March 1, 2020,
our Board approved payment of certain fees to our directors in the amounts of $4,980, $4,980 and $6,950 per month to our directors, Yariv
Alroy, Sagiv Aharon and Erez Nachtomy (each, an “Active Director”), respectively. On April 12, 2020, we also enacted a policy
to pay each director (that is not otherwise an Active Director) an amount of $1,500 for each calendar quarter and $400 for attendance
of each meeting of the Board. On May 12, 2024, the Board approved an increase of $3,050 per month,
in the compensation received by Mr. Erez Nachtomy, from $6,950 per month to $10,000 per month, for his service as a member of the Board.
These amounts are exclusive of Israeli VAT, if applicable.

The following table provides
information regarding compensation earned by, awarded or paid to each person for serving as a director who is not an executive officer
during the fiscal year ended December 31, 2024: